A Phase 1, Randomized, Double-Blind, Placebo Controlled, Single Ascending Dose Study of COR388 HCl in Healthy Volunteers

Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo Controlled, Single Ascending Dose Study of COR388 HCl in Healthy Volunteers

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 10 Oct 2017

At a glance

  • Drugs COR-388 (Primary)
  • Indications Alzheimer's disease; Neurodegenerative disorders
  • Focus First in man; Pharmacokinetics
  • Sponsors Cortexyme
  • Most Recent Events

    • 10 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top